Technical Papers

553 Results

SGS

HEPATITS C VIRUS – RACE FOR TREATMENT

SGS Life Science Services | 23-Sep-2013 | Technical / White Paper

To understand why there is so much buzz in the pharmaceutical world for a better HCV treat­ment, as with most things, you have to start with history. This...

Novozymes

Hyaluronic acid is now measured on the Hyasis® scale

Information not available | 16-Sep-2013 | Technical / White Paper

Hyasis is derived from a state-of-the-art Bacillus-based production process utilizing only water for purification with no animal-derived raw materials...

ACG

ACG Whitepaper – Demystifying Track & Trace

ACG Associated Capsules | 02-Sep-2013 | Technical / White Paper

Read Demystifying Track & Trace and learn how a single-source provider can help to ensure the safety of pharmaceutical drugs by ensuring that all goods...

(b)(2) or not (b)(2)? That is the question.

(b)(2) or not (b)(2)? That is the question.

Camargo Pharmaceutical Services | 19-Aug-2013 | Technical / White Paper

505(b)(2) is more than a regulatory pathway - for many, it’s a unique strategy that can often result in product approval with lower risk, reduced development...

Baxter

Pharmaceutical Development for ADCs

Baxter BioPharma Solutions | 05-Aug-2013 | Case Study

Formulation, process, and analytical development for ADCs is complex. While an aqueous solution formulation may be preferred over a lyophilized product,...

Freund Pharmatec

Novel encapsulation technology for oral delivery

Freund Pharmatec | 17-Jun-2013 | Data Sheet

The Ethicap® Gel technology offers solutions to many common formulation challenges faced by the pharmaceutical industry for oral drug delivery of new molecular...

Mettler Toledo CI-Vision

Avoid Angry Customers-Eliminate Defects

METTLER TOLEDO | 12-Jun-2013 | Technical / White Paper

In the pharmaceutical business, it is crucial that containers be free of contamination, formation defects and dimensional irregularities to avoid the risk...

Understanding the 505(b)(2) Approval Pathway

Understanding the 505(b)(2) Approval Pathway

Camargo Pharmaceutical Services | 11-Jun-2013 | Technical / White Paper

When it comes to developing a compound, the 505(b)(2) drug development pathway is not just a regulatory platform — it’s a different animal. This pathway...

ATMI

Virus Production: From Bench to Industrial Scale

ATMI Life Science | 10-Jun-2013 | Case Study

Discover the linear scale-up of various viral production process using the Integrity® iCELLis®, a scalable range of disposable fixed-bed bioreactors operating...

Follow us

Products

View more

Webinars